Status: Not yet recruiting
Phase I Clinical Trial of Enterovirus Type71 - Coxsackievirus Type A16 Bivalent Vaccine
This is a randomized, double-blinded, placebo-controlled phase I clinical trial to evaluate the safety and preliminary immunogenicity of the Enterovirus Type71 - Coxsackievirus Type A16 bivalent vaccine in subjects ( aged 6 months to 59 years ).
Participants needed: 144
Trial details
Phase: Phase 1Age: 6-59Biological sex: AllType: InterventionalSponsor: Institute of Medical Biology, Chinese Academy of Medical SciencesUpdated: Jan 8, 2026Locations: 1
Eligibility criteria
Age Requirement: volunteers aged 6 months and 59 years. [+5]
Subjects who have been allergic to any component of the vaccine in the past, or... [+19]